Key result
The Impella CP device maintained hemodynamic stability without vascular complications during high-risk percutaneous coronary intervention in two patients with severely depressed left ventricular function.
Why the study?
Does the Impella CP device maintain hemodynamic stability and prevent vascular complications during high-risk PCI in patients with severely depressed left ventricular function?
Case Report (n=2)
Does the Impella CP device maintain hemodynamic stability and prevent vascular complications during high-risk PCI in patients with severely depressed left ventricular function?
The Impella CP device is a promising option for maintaining hemodynamic stability without vascular complications during high-risk PCI in patients with severely depressed LV function.
Answers are grounded in this paper and cite their sources.
Supports Impella CP feasibility in high-risk PCI with low LVEF; hypothesis-generating and should not change practice.
Percutaneous coronary intervention (PCI) has been increasingly performed in patients with severely depressed left ventricular function and complex coronary lesions, including multivessel disease. Mechanical ventricular assist devices play an increasingly important role in high-risk PCI. Impella CP® (Abiomed, Inc.) is a new percutaneous left ventricular assist device, designed for short-term circulatory support. It is a promising option for hemodynamic support in high-risk procedures and can potentially reduce PCI-related complications. The authors present two case reports of high-risk PCI using the Impella CP® device. In the setting of low coronary flow reserve, severely depressed left ventricular function and potential hemodynamic instability, the Impella CP® device has made it possible to maintain hemodynamic stability during procedures, without being associated with vascular complications. As intervenções coronárias percutâneas (ICP) têm sido feitas com maior frequência em doentes com depressão severa da função ventricular esquerda e com lesões coronárias complexas, inclusive doença coronária multivaso. Os dispositivos de assistência ventricular mecânica desempenham um papel cada vez mais importante nas ICP de elevado risco. O Impella CP® (Abiomed, Inc.) é um novo dispositivo percutâneo de assistência ventricular mecânica esquerda, desenvolvido para apoio circulatório de curta duração. Constitui uma opção prometedora de apoio hemodinâmico em procedimentos de elevado risco, com o potencial de reduzir as complicações relacionadas com as ICP. Os autores apresentam dois casos clínicos de ICP de alto risco que usam o dispositivo Impella CP®. No contexto de baixa reserva coronária, depressão severa da função do ventrículo esquerdo e de potencial instabilidade hemodinâmica, o Impella CP® permitiu manter a estabilidade hemodinâmica dos doentes durante os procedimentos, sem se associar a complicações vasculares.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2018) conducted a case report in High-risk percutaneous coronary intervention (n=2). Impella CP was evaluated on Hemodynamic stability and vascular complications. The Impella CP device maintained hemodynamic stability without vascular complications during high-risk percutaneous coronary intervention in two patients with severely depressed left ventricular function.
Synapse has enriched 10 related papers. Consider them for comparative context: